Biotech giant CoreFX establishes new European headquarters in Ireland
The US-based biotechnology firm has officially launched its regional hub to spearhead nutritional innovation. This strategic expansion leverages Ireland's world-class research capabilities to accelerate the development of advanced health ingredients for the European market.
In a major boost for the domestic biotechnology sector, CoreFX Ingredients LLC has officially opened its new European headquarters, CoreNhanced Biotechnology Limited, in Ireland. This significant investment marks a pivotal moment for the US-based firm, which aims to utilise the facility as a central hub for scientific research, commercial expansion, and customer collaboration. By positioning itself within the Irish innovation ecosystem, the company intends to fast-track its proprietary CoreNhanced™ platform, which improves the stability and performance of bioactive molecules across the manufacturing process.
The decision to anchor operations in Ireland was heavily influenced by the nation’s reputation for excellence in food science and access to top-tier scientific talent. The initiative is supported by Enterprise Ireland and features a robust partnership with Teagasc Moorepark, ensuring that the company has access to cutting-edge research facilities. Minister for Enterprise, Tourism and Employment Peter Burke TD welcomed the move, characterising it as a strong endorsement of Ireland’s standing as a global leader in food innovation and biotechnology.
Leading the new Irish operation is Managing Director Trevor Dunne, who brings over twenty years of international experience to the role. The company has already assembled a dedicated scientific team to drive its research goals, with further expansion expected as the business scales. Those interested in learning more about the company’s work and its proprietary technology platform can find additional details on the official website.